Approval · Notice of Compliance 19847 · 2017
SYNAREL: Notice of Compliance 19847
Issued September 22, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19847
- Date
- September 22, 2017
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updatre to the inner and outer labels and the package insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNAREL | Not yet assigned | — |
Medicinal ingredients
- NAFARELIN ACETATE 2 MG per ML